J. Leslie Glick

CLOSE-UP -- J. Leslie Glick (The Scientist, Vol:5, #2, pg. 8, January 21, 1991) (Copyright, The Scientist, Inc.) ---------- J. Leslie Glick, president and chief executive officer of Bionix Inc. of Potomac, Md., insists that he never really intended to start a neurospecialty company. "I essentially had decided to retire," recalls the 68-year-old biologist and biotech executive. "But there are only so many museums in Washington, and I wanted to do something that would benefit the

Written byE. P.
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

J. Leslie Glick, president and chief executive officer of Bionix Inc. of Potomac, Md., insists that he never really intended to start a neurospecialty company. "I essentially had decided to retire," recalls the 68-year-old biologist and biotech executive. "But there are only so many museums in Washington, and I wanted to do something that would benefit the elderly."

Although a molecular and cellular biologist by training, Glick had spent the past 21 years on the business side of genetic engineering. He cofounded Genex Corp. in Gaithersburg, Md., and was its CEO from 1977 to 1987. Before that he helped set up Associated Biomedic Systems, in Buffalo, a biologicals manufacturing company. And in 1981 he helped start, and guided for a time, the Industrial Biotechnology Association, a trade association with a membership of about 100 biotech firms.

After retirement, Glick first considered becoming an ombudsman for a nursing home. But then ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies